International Life Sciences & Biotech Conference

Wed Oct 11, 2023 - Thu Oct 12, 2023

Buy Tickets Buy Tickets Attendees

Interested in sponsoring an event? Contact advertising@bisnow.com

International Life Sciences & Biotech Conference

Name: International Life Sciences & Biotech Conference
Start: 2023-10-11T12:30:00-04:00
End: 2023-10-12T18:00:00-04:00
Location: Pennsylvania Convention Center

Dealmaking, Funding, Top Biotech Markets, Leasing, Graduating from Incubators & The Global Impact from Lab Discoveries

Wednesday October 11-Thursday October 12

$599.00

Get Tickets and Info Attendee List Get Tickets and Info Become A Speaker

Registration Questions? **Please note we have pricing tiers based on ticket availability. Ticket prices will increase once we sell out of the current pricing tier. We cannot redeem a lower price once the ticket prices have been raised. **Bisnow is a cashless, checkless operation. Please only submit payment via credit card.

Group Ticket Savings

Interested in attending this event with a few colleagues? Reach out to us for a discounted group ticket rate for purchases of 4 or more attendees. Email hello@bisnow.com

Speakers and Panels

Investment Outlook: Transactions & Capital Raising

Quentin Reynolds

Chief Investment Officer, The Davis Companies

Thomas Wang

Partner, Chief Investment Officer, Life Sciences, EQT Exeter

Brian Newman

Managing Director, Life Sciences, Ventas

Andrea De Leon

Private Equity, TPG Real Estate

Sava Kobilarov

Managing Partner, Vault Advisors

Moderator

Sabrina Solomiany

Senior Managing Director, Nat'l Head of Life Sciences, Berkadia

Breakthrough Properties Keynote/Fireside Chat

Dan Belldegrun

CEO, Breakthrough Properties

Amy Schulman

Managing Partner, Polaris Partners

Moderator

Susie Harborth

Chief Business Officer, Breakthrough Properties

Building & Designing for Tenant Demands Across All Lab Types

Ben Suzuki

Executive Director, Real Estate, Regeneron Pharmaceuticals

Anthony Guiliano

General Manager, Life Sciences Construction, Lendlease

Alicia Hinds

Head of Asset Management, Alloy Properties

Anthony Montalto

Partner, Jaros Baum & Bolles (JB&B)

Eric Jaffe

Education & Science Global Director, HDR

Moderator

Rick Smith

Vice President, Vicinity Energy

Helping Life Sciences Companies Scale

Kendalle Burlin O’Connell

As CEO and President, Kendalle leads the strategic direction for the organization and drives policy advocacy for the industry to ensure that Massachusetts life sciences companies have the best environment possible to research, develop, manufacture, and commercialize breakthrough therapies and cures for people around the world. Pursuing innovation and delivering for members are the hallmarks of Kendalle’s more than 15 years at MassBio, including the launch of several multi-year initiatives focused on realizing a diverse and equitable life sciences industry, supporting the continued growth and sustainability of the industry throughout Massachusetts, and providing resources and solutions to companies across the industry value chain. Kendalle has played a critical role in MassBio’s growth into the largest life sciences trade association in the world with over 1,600 members. Kendalle has overseen the rebrand of a number of MassBio’s core programs and services, including the MassBioEdge, MassBio’s savings program which offers members access to industry-leading providers and best in class benefit plans, and MassBio’s highly-rated Employee Rewards program. She also led the development of the MassBioHub conference and business center. In 2022, Kendalle was instrumental in the launch of MassBio’s newest entrepreneurial accelerator program, MassBioDrive and MassBio’s Innovation Week, two initiatives focused on advancing breakthrough science and providing opportunities for innovators from diverse backgrounds in all areas of the life sciences ecosystem. In 2023, she has been the driving force behind MassBio’s launch of Bioversity, a non-profit created to develop new training pathways and create employer connections for underrepresented populations and individuals traditionally left out of the life sciences, starting with a workforce training center in Dorchester featuring industry-aligned certification and upskilling programs. This year, she also originated a collaboration with McKinsey & Co. to host an annual partnering conference, the Align Summit, for early-stage investors, startups, and strategic partners. Kendalle has earned wide acclaim for her leadership and is active in mentoring and professional organizations. She is ranked number 33 on Boston Magazine’s list of The 150 Most Influential Bostonians in 2023, a 2022 recipient of the Cambridge Chamber of Commerce Inspire Award recognizing outstanding women leaders in the Cambridge community, a 2022 Boston power player as named by Axios, a 2021 executive fellow in the inaugural class of the Civic Action Project Collaborative, and a 2019 Boston Business Journal 40 under 40 honoree which acknowledges a leader’s impact on Massachusetts’ industries. Currently, Kendalle serves as a Director on the Board of The Boston Foundation, Vice Chair of the Eastern New England Board of Directors for the American Cancer Society, a Director on the Board of the Massachusetts Biotechnology Education Foundation (MassBioEd), and an Advisory Committee member for the Suffolk University Law School All Rise Program. Prior to joining MassBio, Kendalle practiced law in the areas of Estate and Medicaid Planning, Probate and Asset Protection. She graduated cum laude from Sacred Heart University with a B.A. in Economics and Political Science and received her Juris Doctor from Suffolk University Law School. She resides in Haverhill, Massachusetts with her husband and two children.

MassBio

CEO & President

Kendalle Burlin O’Connell

CEO & President, MassBio

Michael Poisel

Executive Director, Penn Center for Innovation

Dora Mitchell

Senior Vice President of Operations, Chief of Staff, Interius Biotherapeutics

Melina Blees

Head of Philadelphia, BioLabs

Tyler Vandegrift

Senior Managing Director, JLL

Moderator

Dipankar Ghosh

Vice President, BioPharma Services, SmartLabs

Creating Biotech & Innovation Hubs

Carl Rodrigues

CEO, Harvard Allston Land Company

Jamie Schwartz

President, Hudson Valley iCampus

Brent Webb

Development Executive, Mortenson Development

Joe Mamayek

Principal, SGA

Moderator

Randal Froebelius

Project Executive & Senior Adviser, MaRS Discovery District

Leasing Outlook: Flexibility, Demand & Lease Terms

Cory Matthews

Head of Real Estate & Asset Management, AstraZeneca

Jeff DeVuono

Senior Managing Director, Brandywine Realty Trust

Paul Touhey

Executive Vice President, CBRE

Dave Hagan

SVP, Netrality Data Centers

Joseph Fetterman

EVP Healthcare and Life Sciences, Colliers

Moderator

Howard Kozloff

Founder & CEO, Noblespace

Why Philly: Growing in this Market & Cell Gene Therapy

Ed Datz

Executive Director, Real Estate, University of Pennsylvania

John Gattuso

CEO, Gattuso Development

Anthony Green

Anthony P. Green, Ph.D., is Chief Scientific Officer for Ben Franklin Technology Partners of Southeastern PA. At Ben Franklin, Dr. Green’s team focuses on Ben Franklin's earliest seed funding program, now representing over $4M in funding to 80 companies and resulting in $50M in follow-on funding; business and pipeline development for investment opportunities and strategic partnershis; managing its mentoring/service/prototyping programs and participation in the region’s research institution’s translational research programs. Dr. Green was instrumental in the creation and management of the Drexel University and Temple University co-investment programs—the first programs of their kind in the country. Dr. Green has helped develop and implement new university/industry partnership/commercialization models for Ben Franklin’s region-wide technology partnerships. Major initiatives in emerging technologies include life sciences/medtech/digital health, advanced textiles, advanced manufacturing, nanotechnology, energy, and IoT. He is a member of the Oversight/Advisory Committees of many of the region’s translational research programs, including the Coulter- Drexel Translational Research Partnership, UPenn’s Singh NanoCenter, Children’s Hospital’s Pediatric Medical Device Consortium and their Innovation Council and the Temple University Professional Science Master’s Program in Bioinnovation and Biotechnology. He is a Board Observer of Atrin Pharmaceuticals. He is also President of the Education Foundation of Lower Merion. Dr. Green has over 30 years experience in the biotechnology industry focusing on diagnostics and gene transfer technologies. Dr. Green’s track record includes research, development and commercialization of cutting-edge technologies primarily through small, emerging companies, including Centocor, BD and Puresyn. Dr. Green earned his Bachelor of Science degree in Immunology, with Honors, from Brown University, in Providence, Rhode Island and his Ph.D. from Temple University School of Medicine, in Microbiology and Immunology.

Ben Franklin Technology Partners

Chief Scientific Officer

Anthony Green

Chief Scientific Officer, Ben Franklin Technology Partners

Scott Mazo

Founder & CEO, University Place Associates

Eli Gurwitz

Chief Investment Officer, Warren Avenue Investors

Claire Greenwood

As the Senior Vice President of Economic Competitiveness, Claire Greenwood is responsible for advancing the Chamber’s work to attract and expand companies, capital, and talent in the Greater Philadelphia region. Through Claire’s direction, she and her team engage C-Suite leaders from Chamber members, partners, and investors to actively work to amplify the region’s competitive advantages and accelerate equitable economic growth. In support of this work, Claire provides leadership for several Chamber-wide initiatives as well as its four Councils (Select Greater Philadelphia, Young Professionals, Arts and Business and CEO Council for Growth). This portfolio is inclusive of leading two industry- specific Action Teams that advance economic competitiveness priorities and activities in the energy and life sciences sectors, implementing a multi-platform approach to the region’s talent and workforce challenges, fostering collaboration and exchange between the creative and business communities, and building the organization’s partnerships and marketing campaigns to ensure that companies and talent “Select” Greater Philadelphia. Claire also serves as the Executive Director of the Chamber’s CEO Council for Growth, a committed group of nearly 60 business, higher education and civic leaders working to make Greater Philadelphia one of the global first-tier 21st-century innovation economies. Claire graduated from the University of Delaware with a BA in Biological Sciences and a minor in psychology and received her MS in Organizational Dynamics from the University of Pennsylvania. Claire is a member of the Board of Directors for Campus Philly, the Philadelphia Convention and Visitors Bureau and the United Way of Greater Philadelphia and Southern New Jersey.

The Chamber of Commerce for Greater Philadelphia

Executive Director & SVP for Economic Competitiveness

Moderator

Claire Greenwood

Executive Director & SVP for Economic Competitiveness, The Chamber of Commerce for Greater Philadelphia

Top International Markets: Global Trends

Dr. Suzet McKinney

Principal & Director of Life Sciences, Sterling Bay

Tom Osha

Executive Vice President, Wexford

Sumit Verma

Senior Vice President Global Strategic Manufacturing, Iovance Biotherapeutics

Abhishek Dhawan

Life Sciences Core Market Leader, DPR Construction

Stephen Blair

Science + Technology Practice Director, CannonDesign

Moderator

Tiffany Wilson

President & CEO, University City Science Center

Site Selection, Building on Spec & Analyzing Tenant Needs

Robert Albro

Partner, Chief Investment Officer, King Street Properties

Miguel Ilzarbe

Global Operations, Foundation Medicine

Francis McDermott

Deputy Director, Real Estate & Maintenance, Sanofi

Tim O'Connell

Senior Principal and Director, Science + Technology, HOK

Scott McNallan

Architectural Design Lead, CRB Group

Moderator

Kurt Lindorfer

Founding Principal, PARADIGM Structural Engineers

A PREMIER 2 DAY LIFE SCIENCES CONFERENCE

Setting the Stage

How can commercial real estate support scientific advancements? With unprecedented growth and demand for the life sciences sector across the globe, Bisnow is hosting a two-day, internationally focused Life Sciences Event, featuring top thought leaders across life sciences investment, commercial development, research, design and the next wave of biotech innovators.

This conference's overall objective is to deliver content and deal-making opportunities at the intersection between the biotech and real estate communities.

What You’ll Learn

Hear from CEOs, CIOs, Presidents, and Heads of Real Estate and Research about how the industry is learning and prioritizing the growth of these mission-driven biotech companies. The most successful real estate transactions and investments in the biotech industry are ones that understand the unique vision of these evolving companies. This event is meant to further connect, educate and inspire innovation in life sciences so that the real estate community can provide a flexible and welcoming home for continued growth in the world's most untapped industry. Key discussions will include:

Public-Private Partnerships
Fundraising & Life Science Investment
Teaching & Training for the Next Generation of Life Science Talent
Key Ingredients for Successful Development & Design Across Various Lab Products
Site Selection & Acquisition Strategies
Top Markets: Following Where Tenants Want to Grow

A Snapshot of Companies Attending

Alloy Properties, Berkadia, Boston Properties, Brandywine Realty Trust, Breakthrough Properties, Center for Breakthrough Medicines, CIC Labs + Innovation Campus, Colliers, Crescent Communities, Cushman & Wakefield, EDGE, EQT Exeter, Foundation Medicine, Frontier Scientific Solutions, GenVault Biorepository, Gilbane Building Company, Gleeds, Harvard Allston Land Company, Hudson Valley iCampus, INTECH Construction, Iovance Biotherapeutics, JLL, JPMorgan Asset Management, King Street Properties, Lendlease, Longfellow Real Estate Partners, Onyx Equities, Oxford University Development, Penn Center for Innovation, Regeneron Pharmaceuticals, Rialto Capital, Sheridan Road Properties, Silverstein, SmartLabs, South Duvall, Sterling Bay, The Davis Companies, Thermo Fisher Scientific, Transwestern, University City Science Center, University of Pennsylvania, University Place Associates, Warren Avenue Investors, Wexford Science + Technology, plus hundreds more!

What Your Ticket Gets You

Access to notable keynote presentations, roundtable discussions, panel insights, targeted networking sessions and cocktail receptions across two days of networking and deal-making in Philly. Bisnow events bring together the biggest power players in each niche sector to identify opportunities, build your network and expand your business.

Get Your Professional Headshot Taken

Biscred will be sponsoring professional headshots at the conference. Stop by their station in the foyer area during one of the time slots below:

Day 1: 12pm - 2pm
Day 2: 11:30am - 1:30pm

For questions, recommendations, comments, or press inquiries please email our Event Producer, Chris Picher at chris.picher@bisnow.com

For speaker or sponsorship interest, click here.

To request disability-related accommodations, please contact ellie.boyle@bisnow.com no later than 10 business days prior to the event.

Venue

Pennsylvania Convention Center
1101 Arch St.
Philadelphia, PA 19107

Ballroom: Ballroom AB (The closest entrance to the ballroom is through 12th and Market Street next to the Hard Rock Café)

Wednesday Post-Event Cocktail: Transportation will be provided from the Convention Center to the cocktail reception.

Parking Information:

We recommend using the Convention Center Parking Facility. Rates and directions can be found at http://www.conventioncenterparking.com/.

HOTEL ROOM BLOCKs: SOLD OUT

After you book your conference ticket, take advantage of Bisnow's preferred rates at either The Notary Hotel or The Philadelphia Marriott Downtown. You can book directly using the links below. Please note, we only have a specified number of rooms allotted at the discount and they are on a first-come, first-serve basis.

The Notary Hotel - $279/night: SOLD OUT
Philadelphia Marriott Downtown - $399/night: SOLD OUT

View other nearby hotel accommodations

Get Directions

Agenda

October 11	Activity
12:00 PM 1:15 PM	Registration & Networking
1:15 PM 2:00 PM	Investment Outlook: Transactions & Capital Raising 1. Gain a better understanding for what types of institutional capital is entering the space and how this impacts development activity 2. Capital Markets outlook for the life sciences industry. Closer look at the accessibility of debt and equity
2:00 PM 2:30 PM	Breakthrough Properties Keynote/Fireside Chat 1. Dan Belldegrun, Amy Schulman and Susie Harborth discuss the latest on biotech trends and capital markets volatility.
2:30 PM 3:15 PM	Building & Designing for Tenant Demands Across All Lab Types 1. From GMP facilities to wet labs to research and development spaces, hear how top designers are accommodating for varying needs 2. Understand what key market factors are determining where companies will build on spec.
3:15 PM 3:45 PM	Coffee, Networking & Dealmaking
3:45 PM 4:30 PM	Helping Life Sciences Companies Scale 1. As tenants need more space, how are developers accommodating flexibility and growth? 2. What are the keys for early stage life sciences companies to have success? How can real estate help foster collaboration?
4:30 PM 5:15 PM	Creating Biotech & Innovation Hubs 1. What types of ground breaking science discoveries are advancing the industry forward? 2. Closer look at different types of labs: cell gene therapy, drug discovery, cancer research, etc.
5:30 PM 7:30 PM	Post-Event Cocktail at Budd Bioworks 1. Hosted at Budd Bioworks with Budd Bioworks at 3431 Fox Street. 2. Shuttles will be provided between the Convention Center and Budd Bioworks. Bisnow staff will direct attendees to these shuttles following the final panel.
October 12	Activity
9:30 AM 10:30 AM	Breakfast, Coffee & Networking
10:30 AM 11:15 AM	Leasing Outlook: Supply & Demand, Pricing & Lease Terms 1. Which types of developments are leasing with the highest rents and what do lease negotiations look like in top markets? 2. Where is there an imbalance of supply and demand and how does this impact deal flow nationwide? 3. How about the subleasing market, how is that shifting market dynamics?
11:15 AM 12:00 PM	Why Philly: Growing in this Market & Cell Gene Therapy 1. Hear from Local Philly life sciences leaders on the evolution of this market and the role gene therapy plays in advancing the city. 2. Learn how the city is accommodating the growth of all sized tenants in this growing ecosystem.
12:00 PM 1:00 PM	Lunch & Networking
1:00 PM 1:45 PM	Top International Markets: Global Trends 1. Boston, Cambridge, San Diego, San Francisco, Philly, London & More 2. Which markets are next and what specific factors lead to high demand?
1:45 PM 2:30 PM	Site Selection, Building on Spec & Analyzing Tenant Needs 1. Downtown developments versus building in the suburbs versus campus-sized projects 2. How do you manage risk and maximize return by determining whether or not to build on spec?
2:30 PM 3:00 PM	Networking

Connect with Other Attendees Now

Typically, our attendee list becomes available the week before an event so you can strategize your networking. ILSBC is not like our other monthly events though. We want to help you get connected and start making plans to meet valuable contacts now.

Network early and arrange meetings ahead of the conference in our exclusive LinkedIn group. If you purchase the attendee list for this event, you'll also receive an invitation to join a private LinkedIn group where you can see and interact with other attendees well in advance.